nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A critical evaluation of the approaches to targeted protein degradation for drug discovery
|
Chopra, Rajesh |
|
2019 |
31 |
C |
p. 5-13 |
artikel |
2 |
Advanced proteomics approaches to unravel protein homeostasis
|
Grandi, Paola |
|
2019 |
31 |
C |
p. 99-108 |
artikel |
3 |
Cereblon modulators: Low molecular weight inducers of protein degradation
|
Chamberlain, Philip P. |
|
2019 |
31 |
C |
p. 29-34 |
artikel |
4 |
Identification and characterization of cancer vulnerabilities via targeted protein degradation
|
Mayor-Ruiz, Cristina |
|
2019 |
31 |
C |
p. 81-90 |
artikel |
5 |
Ligand-induced genetic degradation as a tool for target validation
|
Yesbolatova, Aisha |
|
2019 |
31 |
C |
p. 91-98 |
artikel |
6 |
Monitoring and deciphering protein degradation pathways inside cells
|
Daniels, Danette L. |
|
2019 |
31 |
C |
p. 61-68 |
artikel |
7 |
Protein degradation for drug discovery
|
Ciulli, Alessio |
|
2019 |
31 |
C |
p. 1-3 |
artikel |
8 |
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
|
Pettersson, Mariell |
|
2019 |
31 |
C |
p. 15-27 |
artikel |
9 |
Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins — A review
|
Yang, Chao-Yie |
|
2019 |
31 |
C |
p. 43-51 |
artikel |
10 |
SNIPERs—Hijacking IAP activity to induce protein degradation
|
Naito, Mikihiko |
|
2019 |
31 |
C |
p. 35-42 |
artikel |
11 |
Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms
|
Wertz, Ingrid E. |
|
2019 |
31 |
C |
p. 109-123 |
artikel |
12 |
Targeted protein degradation in vivo with Proteolysis Targeting Chimeras: Current status and future considerations
|
Watt, Gillian F. |
|
2019 |
31 |
C |
p. 69-80 |
artikel |
13 |
Targeted protein degradation mechanisms
|
Zhang, Yi |
|
2019 |
31 |
C |
p. 53-60 |
artikel |